YSY01A, a Novel Proteasome Inhibitor, Induces Cell Cycle Arrest on G2 Phase in MCF-7 Cells via ERα and PI3K/Akt Pathways.
about
Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells.Proteasome Inhibitor YSY01A Abrogates Constitutive STAT3 Signaling via Down-regulation of Gp130 and JAK2 in Human A549 Lung Cancer Cells.Breast Cancer Invasion and Metastasis by mPRα Through the PI3K/Akt Signaling Pathway.Global Expression Profiling and Pathway Analysis of Mouse Mammary Tumor Reveals Strain and Stage Specific Dysregulated Pathways in Breast Cancer Progression.
P2860
YSY01A, a Novel Proteasome Inhibitor, Induces Cell Cycle Arrest on G2 Phase in MCF-7 Cells via ERα and PI3K/Akt Pathways.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
YSY01A, a Novel Proteasome Inh ...... via ERα and PI3K/Akt Pathways.
@ast
YSY01A, a Novel Proteasome Inh ...... via ERα and PI3K/Akt Pathways.
@en
type
label
YSY01A, a Novel Proteasome Inh ...... via ERα and PI3K/Akt Pathways.
@ast
YSY01A, a Novel Proteasome Inh ...... via ERα and PI3K/Akt Pathways.
@en
prefLabel
YSY01A, a Novel Proteasome Inh ...... via ERα and PI3K/Akt Pathways.
@ast
YSY01A, a Novel Proteasome Inh ...... via ERα and PI3K/Akt Pathways.
@en
P2093
P2860
P356
P1433
P1476
YSY01A, a Novel Proteasome Inh ...... via ERα and PI3K/Akt Pathways.
@en
P2093
Bingjie Xue
Fuxiang Ran
Jingrong Cui
P2860
P304
P356
10.7150/JCA.10733
P577
2015-02-06T00:00:00Z